Inaugural drug discovery grants target malaria, tuberculosis, leishmaniasis, E. Coli, and sleeping sickness
Eight African research projects have won seed funding for drug discovery studies on diseases that disproportionately affect the continent.
The projects, announced on 20 September, will receive US$100,000 each over two years for research into novel treatments for diseases like tuberculosis, malaria, and leishmaniasis.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.